CHR d'Orléans

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study Evaluating Combination of Luspatercept in LR-MDS Without RS Having Failed or Being Ineligible to ESA	Hemic and Lymphatic Diseases, bone marrow disorder, hematologic disorder, myelodysplastic syndrome	Recruiting	Phase 1 / Phase 2	2026-09-29		NCT05181735
PRediction Of DIverse Glucocorticoids toxIcity OUtcomeS	Bacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, acquired idiopathic inflammatory myopathy, anti-neutrophil cytoplasmic antibody-associated vasculitis, arteritis, arthritic joint disease, arthropathy, autoimmune disease, autoimmune disorder of the nervous system, bacterial infectious disease, brain disorder, cardiovascular disorder, central nervous system disorder, central nervous system vasculitis, cerebrovascular disorder, connective tissue disorder, gram-positive bacterial infections, immune system disorder, muscle tissue disorder, musculoskeletal system disorder, myositis disease, necrotizing vasculitis, nervous system disorder, neuromuscular disease, polymyalgia rheumatica, rheumatic disorder, rheumatic fever, skin disorder, skin vascular disease, streptococcal infection, temporal arteritis, vascular disorder, vasculitis	Active, not recruiting	Not stated	2026-06-12		NCT04664465

Clinical trials